ANDHealth+ Program provides mid-stage digital health companies with support from proven experts to undertake a significant piece of work focused on securing the clinical and/or commercial evidence to support the raising of growth capital and progress market entry strategy. No transfer of equity or intellectual property rights is required to be a participant in the ANDHealth+ program.
Applications to ANDHealth+ are currently closed as we work with our 2017 cohort
Applications are closed. Next ANDHealth+ round will open early Q2 2018